Sep
15
2025
15
2025
Revolutionizing C. difficile Prevention
A first-of-its-kind microbiome-based platform for C. difficile relapse prevention - proven, patent-protected, and ready for food & pharma partners.
Read More
Pioneers in the development of bacterial spores as heat stable mucosal vaccines. Oral and sub-lingual delivery.
Expertise in Bacillus probiotics. Development and licensing of novel Bacillus carotenoid rich strains.
Development of Bacillus spores for directed targeting of cancerous cells with anti-tumour drugs
Strain constructions, genetic engineering of Bacillus, QPS and GRAS safety assessments, and more
A first-of-its-kind microbiome-based platform for C. difficile relapse prevention - proven, patent-protected, and ready for food & pharma partners.
Read More